- Researchers have discovered that Melatonin may help treat blood cancers like leukemia and lymphoma
- Melatonin’s involvement in regulation of circadian rhythms may help in coordination and synchronization of internal body functions
- Anti-cancer actions of melatonin are expected to be helpful in facilitating basic research
Washington D.C. [USA], September 3, 2017: Researchers have discovered that blood cancers such as leukemia and lymphoma may be treated with a hormone produced by a small gland in the brain.
Melatonin, a hormone produced by a small gland in the brain may be able to treat blood cancers like leukemia and lymphoma, according to the researchers.
The findings suggest that melatonin performs a number of tasks such as boosting the immune response against cancer cells, inhibiting the growth of cancer cells and even protecting the healthy cells from chemotherapy’s toxic effects.
Melatonin’s involvement in regulation of circadian rhythms may help in the coordination and synchronization of internal body functions. The timings of he melatonin treatment may be grave in regard to their anti-cancer effects.
Senior author Yang Yang hopes that this information would prove helpful in the design of studies concerned with the therapeutic efficiency of melatonin in blood cancers.
The researchers have noted that the anti-cancer actions of melatonin will be helpful in facilitating clinical applications and basic research.
The study has appeared in British Journal of Pharmacology.
-prepared by Samiksha Goel of NewsGram. Twitter @goel_samiksha
This post was last modified on September 4, 2017 12:39